Fig. 1 | Leukemia

Fig. 1

From: Ixazomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma: long-term follow-up including ixazomib maintenance

Fig. 1

Changes in response rates during induction and maintenance. a Deepening of response during the maintenance phase, b kinetics of response during induction and maintenance in all patients (N = 64), c kinetics of response during induction and maintenance in patients who did not proceed to stem cell transplantation (N = 41), and d kinetics of response during induction and maintenance in patients who received maintenance (N = 25)

Back to article page